PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
PART 06: Infectious disease landscape in the US
• Reimbursement in US
• Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration
• Five forces analysis
PART 07: Market segmentation by technology
• Molecular diagnostic test
• POCT for infectious diseases
• Immunodiagnostic tests
PART 08: Market segmentation by application
PART 09: Market segmentation by product
• Equipment
• Consumables
PART 10: Market drivers
• NAFTA
• Demand for rapid and automated diagnostics
• Shift toward patient-centered model
• Focus on disease management
PART 11: Impact of drivers
PART 12: Market challenges
• Medical device excise tax law
• Increase in globalization
• New microbial diseases
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Development of innovative diagnostics initiatives
• Key role of US Army Medical Research Institute in Diagnostics and Development (USAMRIID)
• Low-cost microfluidic devices for POCT
• Focus on early diagnosis of infectious diseases
PART 15: Vendor landscape
• Competitive scenario
• Abbott Diagnostics
• Alere
• Roche Diagnostics
• Siemens Healthcare
• Beckman Coulter Diagnostics
• Other prominent vendors
PART 16: Key vendor analysis
• Abbott Diagnostics
• Alere
• Beckman Coulter
• Roche Diagnostics
• Siemens Healthcare
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Infectious disease testing market in US 2014-2019 ($ billions)
Exhibit 03: Average Medicare payments for infectious diseases
Exhibit 04: Five forces analysis
Exhibit 05: Segmentation of infectious disease testing market in US based on technology
Exhibit 06: Molecular diagnostic testing market in US 2014-2019 ($ billions)
Exhibit 07: POCT diagnostic testing market for infectious diseases in US 2014-2019 ($ billions)
Exhibit 08: Immunodiagnostic tests for infectious disease market in US 2014-2019 ($ billions)
Exhibit 09: Segmentation of infectious disease market in US by technology 2014
Exhibit 10: POCT for infectious diseases market in US by application
Exhibit 11: Segmentation of POCT for infectious disease market in US 2014
Exhibit 12: Infectious disease testing market in US by product
Exhibit 13: Segmentation of infectious disease testing market in US by product 2014
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Key Takeaways: Abbott Diagnostics
Exhibit 17: Key takeaways: Alere
Exhibit 18: Key takeaways: Roche Diagnostics
Exhibit 19: Key takeaways: Siemens Healthcare
Exhibit 20: Key takeaways: Beckman Coulter Diagnostics
Exhibit 21: Abbott Diagnostics: Key business offerings
Exhibit 22: Alere: Business segmentation by revenue 2014
Exhibit 23: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 24: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
Exhibit 25: Beckman Coulter: Business segmentation
Exhibit 26: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 28: Roche Diagnostics: Segmentation of revenue by regions 2014
Exhibit 29: Siemens Healthcare: Business segmentation
Exhibit 30: Siemens Healthcare: Segmentation of revenue by geography 2014
【掲載企業】
Abbott Diagnostics, Alere, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, Life Technologies, Maxim Biomedical, Mindray, OraSure Technologies, Ortho Clinical Diagnostics, Quidel Corporation, Thermo Fisher Scientific, Trinity Biotech.
【資料のキーワード】
感染症検査、分子診断検査、POC検査、免疫診断検査、アメリカ、感染症検査装置、感染症診断
【調査方法】
一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)
【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。